pH-Dependent Solubility and Dissolution Behavior of Carvedilol-Case Example of a Weakly Basic BCS Class II Drug

被引:144
作者
Hamed, Rania [1 ]
Awadallah, Areeg [1 ]
Sunoqrot, Suhair [1 ]
Tarawneh, Ola [1 ]
Nazzal, Sami [2 ]
AlBaraghthi, Tamadur [1 ]
Al Sayyad, Jihan [1 ]
Abbas, Aiman [3 ]
机构
[1] Al Zaytoonah Univ Jordan, Fac Pharm, Dept Pharm, POB 130Amman, Amman 11733, Jordan
[2] Univ Louisiana Monroe, Sch Pharm, Coll Hlth & Pharmaceut Sci, Monroe, LA 71201 USA
[3] Hikma Pharmaceut, POB 182400Amman, Amman 11118, Jordan
关键词
buffer species; carvedilol; dissolution; ionic strength; solubility; POORLY SOLUBLE DRUGS; IN-VIVO PERFORMANCE; SOLID DISPERSION; SMALL-INTESTINE; IONIC-STRENGTH; PRECIPITATION; ABSORPTION; RELEASE; ACID; KETOPROFEN;
D O I
10.1208/s12249-015-0365-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The objective of this study was to investigate the pH-dependent solubility and dissolution of weakly basic Biopharmaceutical Classification Systems (BCS) class II drugs, characterized by low solubility and high permeability, using carvedilol, a weak base with a pK (a) value of 7.8, as a model drug. A series of solubility and in vitro dissolution studies was carried out using media that simulate the gastric and intestinal fluids and cover the physiological pH range of the GI from 1.2 to 7.8. The effect of ionic strength, buffer capacity, and buffer species of the dissolution media on the solubility and dissolution behavior of carvedilol was also investigated. The study revealed that carvedilol exhibited a typical weak base pH-dependent solubility profile with a high solubility at low pH (545.1-2591.4 mu g/mL within the pH range 1.2-5.0) and low solubility at high pH (5.8-51.9 mu g/mL within the pH range 6.5-7.8). The dissolution behavior of carvedilol was consistent with the solubility results, where carvedilol release was complete (95.8-98.2% released within 60 min) in media simulating the gastric fluid (pH 1.2-5.0) and relatively low (15.9-86.2% released within 240 min) in media simulating the intestinal fluid (pH 6.5-7.8). It was found that the buffer species of the dissolution media may influence the solubility and consequently the percentage of carvedilol released by forming carvedilol salts of varying solubilities. Carvedilol solubility and dissolution decreased with increasing ionic strength, while lowering the buffer capacity resulted in a decrease in carvedilol solubility and dissolution rate.
引用
收藏
页码:418 / 426
页数:9
相关论文
共 44 条
[21]   Characterization of agglomerated carvedilol by hot-melt processes in a fluid bed and high shear granulator [J].
Kukec, Simon ;
Dreu, Rok ;
Vrbanec, Tomislav ;
Srcic, Stane ;
Vrecer, Franc .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2012, 430 (1-2) :74-85
[22]   LC and LC-MS Evaluation of Stress Degradation Behavior of Carvedilol [J].
Lanzanova, Fibele Analine ;
Argenta, Debora ;
Arend, Marcela Zart ;
Brum Junior, Liberato ;
Cardoso, Simone Goncalves .
JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, 2009, 32 (04) :526-543
[23]   Characterization of fluids from the stomach and proximal jejunum in men and women [J].
Lindahl, A ;
Ungell, AL ;
Knutson, L ;
Lennernas, H .
PHARMACEUTICAL RESEARCH, 1997, 14 (04) :497-502
[24]   Carvedilol: Solubilization and cyclodextrin complexation: A technical note [J].
Loftsson, Thorsteinn ;
Vogensen, Stine Byskov ;
Desbos, Cyrielle ;
Jansook, Phatsawee .
AAPS PHARMSCITECH, 2008, 9 (02) :425-430
[25]   Preparation and Evaluation of Self-nanoemulsifying Tablets of Carvedilol [J].
Mahmoud, Enas A. ;
Bendas, Ehab R. ;
Mohamed, Magdy I. .
AAPS PHARMSCITECH, 2009, 10 (01) :183-192
[26]   Simulated Biological Fluids with Possible Application in Dissolution Testing [J].
Marques, Margareth R. C. ;
Loebenberg, Raimar ;
Almukainzi, May .
DISSOLUTION TECHNOLOGIES, 2011, 18 (03) :15-28
[27]   DISSOLUTION OF IONIZABLE DRUGS IN BUFFERED AND UNBUFFERED SOLUTIONS [J].
OZTURK, SS ;
PALSSON, BO ;
DRESSMAN, JB .
PHARMACEUTICAL RESEARCH, 1988, 5 (05) :272-282
[28]   The effects of food on the dissolution of poorly soluble drugs in human and in model small intestinal fluids [J].
Persson, EM ;
Gustafsson, AS ;
Carlsson, AS ;
Nilsson, RG ;
Knutson, L ;
Forsell, P ;
Hanisch, G ;
Lennernäs, H ;
Abrahamsson, B .
PHARMACEUTICAL RESEARCH, 2005, 22 (12) :2141-2151
[29]   Formulation and in vivo human bioavailability of dissolving tablets containing a self-nanoemulsifying itraconazole solid dispersion without precipitation in simulated gastrointestinal fluid [J].
Piao, Zong-Zhu ;
Choe, Jae-Seung ;
Oh, Kyung Teak ;
Rhee, Yun-Seok ;
Lee, Beom-Jin .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 51 :67-74
[30]   Carvedilol dissolution improvement by preparation of solid dispersions with porous silica [J].
Planinsek, Odon ;
Kovacic, Borut ;
Vrecer, Franc .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2011, 406 (1-2) :41-48